ROSE MAINA: Open Payments
NPI 1366786618 · BURLESON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,811 in 94 payments from 16 companies in 2025. Trend: 2023 $2,172 · 2024 $1,314 · 2025 $1,811
Food & beverage: $1,811
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $342 |
| Insmed, Inc. | 15 | $248 |
| Inspire Medical Systems, Inc. | 4 | $205 |
| GlaxoSmithKline, LLC. | 13 | $145 |
| Verona Pharma, Inc. | 8 | $139 |
| Viatris Specialty LLC | 7 | $139 |
| Regeneron Healthcare Solutions, Inc. | 9 | $135 |
| Amgen Inc. | 5 | $92 |
| Avadel CNS Pharmaceuticals, LLC | 5 | $92 |
| JAZZ PHARMACEUTICALS INC. | 4 | $89 |
Products named: INSPIRE, TEZSPIRE, Arikayce, DUPIXENT, Ohtuvayre, YUPELRI, FASENRA, LUMRYZ.
Industry payments across TX — which companies pay providers there.
